FeF Chemicals was fully acquired by Novo Nordisk A/S in 1992. Novo Nordisk is the a world leader in the treatment of diabetes and the largest manufacturer of insulin in the world.

The name change comes as FeF Chemicals wish to find a new name that would reflect their focus and future aspirations. The new name reflects the connection to their parent company and at the same time reflects their business focus on pharma and biopharm customers.

As for the “FeF” name, the acronym will not disappear since the brands decision to name their Quat products “FeF Quats”.

Another change see’s SAP implemented as the companies new enterprise resource planning system. It will be used from September 1st 2015.

FeF’s site addresses and phone numbers will remain unchanged. Email addresses will as of Sept 1st 2015 end with @novonordiskpharmatech.com, however current @fefchemicals.com addresses will remain active and will be automatically re-directed.